Search

Bo E Hedlund

from Minneapolis, MN
Age ~79
Get Report
Also known as:
Bo Eric Hedlund, Bob A Hedlund, Vo E Hedlund
Related to:
Amirali Y Ali, 77Corazon RossmanCharles Rossman, 72Roy LarsenEdward RossmanMary Rossman
Connected to:
Adaline E Hedlund, 34Andy P Hedlund, 59Brady A Hedlund, 29Carol J Hedlund, 60Casey J Hedlund, 44David S Hedlund, 58Donna J Hedlund, 69Erin J Hedlund, 33Galen W Hedlund, 53George E Hedlund, 89

Bo Hedlund Phones & Addresses

  • Minneapolis, MN
  • 2049 16Th St NW, New Brighton, MN 55112 (651) 633-6721
  • 241 Cleveland Ave S, Saint Paul, MN 55105

Resumes

Resumes

Bo Hedlund Photo 1

President, Biomedical Frontiers Consulting

View page
Position:
President at Biomedical Frontiers Consulting
Location:
Greater Minneapolis-St. Paul Area
Industry:
Pharmaceuticals
Work:
Biomedical Frontiers Consulting since 2011
President
Biomedical Frontiers, Inc. Jul 1988 - Jun 2011
President & CEO
Education:
University of Minnesota-Twin Cities 1968 - 1973
Ph.D., Biochemistry
Skills:
Biotechnology
Lifesciences
Pharmaceutical Industry
FDA
Drug Discovery
Clinical Trials
Drug Delivery
Contract Manufacturing
Clinical Research
Biochemistry
Antibodies
Licensing
Patents
R&D
Bo Hedlund Photo 2

Bo Hedlund

View page
Bo Hedlund Photo 3

Bo Hedlund

View page
Bo Hedlund Photo 4

Bo Hedlund

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Bo E. Hedlund
President
Biomedical Frontiers Inc
Research & Development
1000 Westgate Dr, Saint Paul, MN 55114

Publications

Us Patents

Modified Polysaccharides Exhibiting Altered Biological Recognition

View page
US Patent:
6479468, Nov 12, 2002
Filed:
Aug 1, 2000
Appl. No.:
09/555994
Inventors:
Bo E. Hedlund - New Brighton MN
Thomas P. Weber - San Diego CA
Paul R. Dragsten - Chanhassen MN
Gregory J. Hanson - Fridley MN
Philip E. Hallaway - Minneapolis MN
Assignee:
Biomedical Frontiers, Inc. - Minneapolis MN
International Classification:
A61K 3170
US Classification:
514 60, 536105
Abstract:
The invention relates to polysaccharides, polysaccharide conjugates with altered biological properties, and methods to produce these polysaccharides and conjugates.

Modified Polysaccharides Exhibiting Altered Biological Recognition

View page
US Patent:
6780852, Aug 24, 2004
Filed:
Nov 12, 2002
Appl. No.:
10/293910
Inventors:
Bo E. Hedlund - New Brighton MN, 55112
Thomas P. Weber - Surrey B.C., V9A 9X4, CA
Paul R. Dragsten - Minneapolis MN, 55413
Gregory J. Hanson - Fridley MN, 55432
Philip E. Hallaway - Minneapolis MN, 55403
International Classification:
A61K 3170
US Classification:
514 60, 514 54, 514 59, 536105
Abstract:
The invention relates to polysaccharides, polysaccharide conjugates and complexes with altered biological properties, and methods to produce these polysaccharides, polysaccharide conjugates and complexes.

Modified Polysaccharides Exhibiting Altered Biological Recognition

View page
US Patent:
20030236224, Dec 25, 2003
Filed:
May 1, 2003
Appl. No.:
10/429211
Inventors:
Bo Hedlund - New Brighton MN, US
Thomas Weber - Surrey, CA
Paul Dragsten - Minneapolis MN, US
Gregory Hanson - Fridley MN, US
Philip Hallaway - Minneapolis MN, US
International Classification:
A61K031/717
C08B033/00
US Classification:
514/060000, 536/106000
Abstract:
The invention relates to polysaccharides, polysaccharide conjugates and polysaccharide complexes with altered biological properties, methods to produce these polysaccharides, polysaccharide conjugates and polysaccharide complexes and methods to use these conjugates and complexes in the treatment of iron overload or iron deficiency diseases.

Polymer-Deferoxamine-Ferric Iron Adducts For Use In Magnetic Resonance Imaging

View page
US Patent:
52681653, Dec 7, 1993
Filed:
Aug 7, 1992
Appl. No.:
7/926906
Inventors:
Bo E. Hedlund - New Brighton MN
Philip E. Hallaway - Minneapolis MN
Assignee:
Biomedical Frontiers, Inc. - Minneapolis MN
International Classification:
G01N 2408
A61K 3714
A61K 31715
US Classification:
424 9
Abstract:
Compositions comprising a covalently bounded adduct of deferoxamine, ferric iron and polymer for image enhancement in magnetic resonance (MR) imaging are provided. A pharmaceutical composition comprising the adduct and method of using the composition in magnetic resonance imaging are also disclosed.

Fluid Resuscitation

View page
US Patent:
54160782, May 16, 1995
Filed:
Nov 25, 1992
Appl. No.:
7/949522
Inventors:
Bo E. Hedlund - New Brighton MN
Philip E. Hallaway - Minneapolis MN
Assignee:
Biomedical Frontiers, Inc. - Minneapolis MN
International Classification:
A61K 31715
A61K 31185
US Classification:
514 58
Abstract:
The invention relates to fluid resuscitation of the human or animal body by administration of deferoxamine (DFO) and a water-soluble biopolymer. The DFO and the biopolymer are preferably bonded together. The biopolymer may be a polysaccharide or a protein. The DFO and the biopolymer are preferably formulated as an aqueous solution suitable for oral administration. The fluid resuscitation may be effected for ameliorating systemic oxidant injury occurring during ischemia and subsequent reperfusion. The fluid resuscitation may be indicated in treatment of burn injury, lung injury caused by inhalation of hot and/or toxic substances, such as smoke derived from combustion, hemorrhagic shock and other types of trauma.

Method For The Stabilization Of Deferoxamine To Chelate Free Ions In Physiological Fluid

View page
US Patent:
48639648, Sep 5, 1989
Filed:
Aug 20, 1987
Appl. No.:
7/087631
Inventors:
Bo E. Hedlund - New Brighton MN
Philip E. Hallaway - Minneapolis MN
Samuel S. Panter - Minneapolis MN
John W. Eaton - Minneapolis MN
Assignee:
Biomedical Frontiers, Inc. - Minneapolis MN
International Classification:
A61K 31715
A61K 31185
US Classification:
514575
Abstract:
A method for scavenging free iron or aluminum in fluids such as physiological fluids involves a provision in such fluids of a soluble polymer substrate having chelator immobilized thereon. According to the invention preferred such compounds comprise polysaccarides or proteins having a deferoxamine moiety thereon. Such a compound can be used for the treatment of iron overload, as well as to inhibit cell damage from oxidation/reduction reactions. In one embodiment, cell damage during reperfusion is inhibited, through provision of the chelating moiety at the site of reperfusion.

Composition For The Stabilization Of Deferoxamine To Chelate Free Ions In Physiological Fluid

View page
US Patent:
52179982, Jun 8, 1993
Filed:
Jun 17, 1991
Appl. No.:
7/715881
Inventors:
Bo E. Hedlund - New Brighton MN
Philip E. Hallaway - Minneapolis MN
Samuel S. Panter - Minneapolis MN
John W. Eaton - Minneapolis MN
Assignee:
Biomedical Frontiers, Inc. - Minneapolis MN
International Classification:
A61K 31185
US Classification:
514575
Abstract:
A method for scavenging free iron or aluminum in fluids such as physiological fluids involves a provision in such fluids of a soluble polymer substrate having chelator immobilized thereon. According to the invention preferred such compounds comprise polysaccharides or proteins having a deferoxamine moiety thereon. Such a compound can be used for the treatment of iron overload, as well as to inhibit cell damage from oxidation/reduction reactions. In one embodiment, cell damage during reperfusion is inhibited, through provision of the chelating moiety at the site of reperfusion.
Control profile
Bo E Hedlund from Minneapolis, MN, age ~79 Get Report